Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery-Reference-Cited by-同舟云学术

Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery

Published:2018-12-03 Issue:1 Volume:4 Page:152-163
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioengineering & Translational Medicine

Author:

Schlesinger Erica B.¹²,Bernards Daniel A.³,Chen Hunter H.²,Feindt James²,Cao Jingtai⁴,Dix Daniel²,Romano Carmelo⁴,Bhisitkul Robert B.⁵,Desai Tejal A.¹³

Affiliation:

1. Graduate Program in Bioengineering; University of California; San Francisco CA 94158

2. Formulation Development Group; Regeneron Pharmaceuticals; Tarrytown NY 10591

3. Dept. of Bioengineering and Therapeutic Sciences; University of California; San Francisco CA 94158

4. Ophthalmology Research; Regeneron Pharmaceuticals; Tarrytown NY 10591

5. Dept. of Ophthalmology; University of California; San Francisco CA 94158

Funder

National Eye Institute

Regeneron Pharmaceuticals

San Francisco State University

That Man May See Foundation

Research to Prevent Blindness

National Institutes of Health

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/btm2.10121/fullpdf

Reference38 articles.

1. Recent perspectives on the delivery of biologics to back of the eye;Joseph;Expert Opin Drug Deliv,2016

2. Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye

3. Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins;Radhakrishnan;Drug Discov Today,2017

4. Randomized, double-masked, sham-controlled trial of Ranibizumab for Neovascular age-related macular degeneration: PIER study year 2;Abraham;Am J Ophthalmol,2010

5. HORIZON: an open-label extension trial of Ranibizumab for choroidal neovascularization secondary to age-related macular degeneration;Singer;Ophthalmology,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable Devices for Delivery of Liquid or Solid Protein Formulations;ACS Materials Au;2023-03-13

2. Progress in Ocular Drug Delivery: Challenges and Constraints;Handbook of Experimental Pharmacology;2023

3. Tuning polycaprolactone degradation for long acting implantables;Polymer;2022-12

4. Long-acting formulation strategies for protein and peptide delivery in the treatment of PSED;Journal of Controlled Release;2022-10

5. Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina;Drug Delivery and Translational Research;2022-09-21